Navigation Links
APCER Pharma Sponsors Major Industry Conference
Date:6/21/2012

Princeton, NJ (PRWEB) June 21, 2012

APCER Pharma Solutions, Inc., the truly global provider of strategic and operational services in safety reporting, medical affairs, and regulatory operations, announced today that it is sponsoring and exhibiting at the 48th Annual Meeting of the Drug Information Association (DIA). The meeting takes place at the Philadelphia Convention Center, June 24-28, 2012, and is expected to draw more than 7,000 professionals from the pharmaceutical, biotechnology, and medical device industries.

“We have been exhibiting at the DIA Annual Meeting since our founding, and it has provided an informal platform for our global safety experts to communicate with the industry professionals that bear the responsibility for regulatory compliance for their companies,” said Suneet Walia, President and CEO of APCER Pharma. “We are pleased to be able to support the meeting even further this year through sponsorship of the DIA Welcome Reception.”

DIA is a neutral, global, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices and related medical products. Its Annual Meeting features more than 270 sessions presented by top experts across government, industry, academia, and patient groups, along with exhibitors from contract research organizations, technology providers, research centers, and academia. APCER Pharma will have representatives from its offices in North America, Europe, and Asia available at Booth #2736 to share information regarding developments in global safety regulations and client engagement models that drive quality and compliance.

About APCER Pharma Solutions
APCER Pharma is a global provider of strategic and operational services in safety reporting, medical affairs, and regulatory operations. Its international team of highly experienced healthcare professionals, scientists, and technologists provides pharmaceutical, biotechnology, medical device, and consumer product companies with deep knowledge of worldwide regulations and best practices to comply with them. For more information on APCER Pharma Solutions, please call (+1) 609-455-1600, or visit the company website at http://www.apcerpharma.com.

Read the full story at http://www.prweb.com/releases/pharmacovigilance/apcerpharma/prweb9626562.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. ePharmaSolutions To Acquire Global Patient Recruitment Firm Polaris BioPharma
2. WHEATON® Introduces a New Web Community for Scientists, Researchers, and Biopharmaceutical Packagers
3. Keryx Biopharmaceuticals Announces Live Webcast of Upcoming Analyst Day
4. Sinovac to Present at 55th Annual BioPharma China Convention 2012 - Vaccine & Antibody Focus
5. aTyr Pharma Receives Industry Innovation Awards from TiE and San Diego Venture Group
6. Big Pharma and Universities Increasingly Work to Advance Life Science Knowledge by Forming Strategic Partnerships, Public-Private Partnerships, and Open Innovation Programs: Pharmaceutical Research Collaborations Summit
7. Auxilium Pharmaceuticals, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
8. Rising Interest of Big Pharma Creates Immense Growth Potential for Contract Manufacturing Organisations, Says Frost & Sullivan
9. Questcor Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference
10. Genesis Biopharma Mentioned Favorably in BioMedReports Article
11. Genesis Biopharma Issues Letter To Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator ... Members of the Class of 2016 were selected from a pool of 128 ... About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , ... June 23, 2016 , ... In a new ... in Denmark detail how a patient who developed lymphedema after being treated for breast ... results could change the paradigm for dealing with this debilitating, frequent side effect of ...
Breaking Biology Technology:
(Date:5/16/2016)... 16, 2016   EyeLock LLC , a market ... opening of an IoT Center of Excellence in ... the development of embedded iris biometric applications. ... convenience and security with unmatched biometric accuracy, making it ... from DNA. EyeLock,s platform uses video technology to deliver ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
(Date:4/19/2016)... , UAE, April 20, 2016 ... implemented as a compact web-based "all-in-one" system solution for ... biometric fingerprint reader or the door interface with integration ... modern access control systems. The minimal dimensions of the ... readers into the building installations offer considerable freedom of ...
Breaking Biology News(10 mins):